Jennison Associates’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-47,899
| Closed | -$984K | – | 622 |
|
|
2024
Q3 | $984K | Buy |
47,899
+8,497
| +22% | +$175K | ﹤0.01% | 488 |
|
|
2024
Q2 | $882K | Buy |
39,402
+5,786
| +17% | +$129K | ﹤0.01% | 498 |
|
|
2024
Q1 | $925K | Buy |
33,616
+9,768
| +41% | +$269K | ﹤0.01% | 509 |
|
|
2023
Q4 | $727K | Buy |
23,848
+4,949
| +26% | +$151K | ﹤0.01% | 526 |
|
|
2023
Q3 | $598K | Buy |
18,899
+871
| +5% | +$27.5K | ﹤0.01% | 523 |
|
|
2023
Q2 | $735K | Buy |
+18,028
| New | +$735K | ﹤0.01% | 519 |
|
|
2022
Q2 | – | Sell |
-310,036
| Closed | -$22.5M | – | 673 |
|
|
2022
Q1 | $22.5M | Sell |
310,036
-725,362
| -70% | -$52.7M | 0.02% | 337 |
|
|
2021
Q4 | $122M | Buy |
1,035,398
+116,821
| +13% | +$13.8M | 0.08% | 108 |
|
|
2021
Q3 | $123M | Sell |
918,577
-148,920
| -14% | -$20M | 0.08% | 103 |
|
|
2021
Q2 | $173M | Sell |
1,067,497
-72,374
| -6% | -$11.7M | 0.11% | 85 |
|
|
2021
Q1 | $91.5M | Buy |
1,139,871
+987,773
| +649% | +$79.3M | 0.07% | 125 |
|
|
2020
Q4 | $8.27M | Buy |
+152,098
| New | +$8.27M | 0.01% | 418 |
|